BIOCYTOGEN-B (02315): 富国基金管理有限公司 sold 831,500 shares of BIOCYTOGEN-B on the SEHK open market at an average of HKD 39.2333 per share on November 3, 2026, involving about HKD 32.62 million; this was an on-exchange active trade matched on the SEHK open market, constituting a direct secondary-market dealing.
Prior to the disposal, 富国基金管理有限公司’s long position in BIOCYTOGEN-B was 10.35 million shares, representing 9.34%; following the disposal, the holding changed to 9.52 million shares, with the long position ratio falling to 8.59%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments